HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.
about
Application of nucleoside analogues to liver transplant recipients with hepatitis BComplete withdrawal of hepatitis B virus prophylaxis after liver transplantation in a recipient at high risk of recurrence.Recent advances in prevention of hepatitis B recurrence after liver transplantation.A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis.Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management.
P2860
HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
HBIG Remains Significant in th ...... e After Liver Transplantation.
@en
type
label
HBIG Remains Significant in th ...... e After Liver Transplantation.
@en
prefLabel
HBIG Remains Significant in th ...... e After Liver Transplantation.
@en
P2093
P2860
P1476
HBIG Remains Significant in th ...... e After Liver Transplantation.
@en
P2093
Kymberly D Watt
Lance Lindberg
Sophoclis Alexopoulos
P2860
P304
P356
10.3109/08830185.2014.921160
P577
2014-06-09T00:00:00Z